Comment
doi: 10.1056/NEJMc066096.
Epub 2006 Feb 22.
Response to expression of concern regarding VIGOR study
- PMID: 16495387
- DOI: 10.1056/NEJMc066096
Item in Clipboard
Comment
Response to expression of concern regarding VIGOR study
N Engl J Med.
.
No abstract available
Comment on
-
Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8.N Engl J Med. 2005 Dec 29;353(26):2813-4. doi: 10.1056/NEJMe058314. Epub 2005 Dec 8. N Engl J Med. 2005. PMID: 16339408 No abstract available.
-
Expression of concern reaffirmed.N Engl J Med. 2006 Mar 16;354(11):1193. doi: 10.1056/NEJMe068054. Epub 2006 Feb 22. N Engl J Med. 2006. PMID: 16495386 No abstract available.
Similar articles
-
Response to expression of concern regarding VIGOR study.N Engl J Med. 2006 Mar 16;354(11):1196-9. N Engl J Med. 2006. PMID: 16544387 No abstract available.
-
Expression of concern reaffirmed.N Engl J Med. 2006 Mar 16;354(11):1193. doi: 10.1056/NEJMe068054. Epub 2006 Feb 22. N Engl J Med. 2006. PMID: 16495386 No abstract available.
-
Effects of rofecoxib and naproxen on life expectancy among patients with rheumatoid arthritis: a decision analysis.Am J Med. 2004 May 1;116(9):621-9. doi: 10.1016/j.amjmed.2003.09.050. Am J Med. 2004. PMID: 15093759
-
Life after Vioxx: the clinical implications.Hosp Med. 2005 May;66(5):264-7. doi: 10.12968/hmed.2005.66.5.18418. Hosp Med. 2005. PMID: 15920854 Review. No abstract available.
-
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.Pharmacoepidemiol Drug Saf. 2003 Jan-Feb;12(1):67-70. doi: 10.1002/pds.798. Pharmacoepidemiol Drug Saf. 2003. PMID: 12616850 Review. No abstract available.
Cited by
-
The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks.Can J Cardiol. 2007 Feb;23(2):125-31. doi: 10.1016/s0828-282x(07)70732-8. Can J Cardiol. 2007. PMID: 17311118 Free PMC article. Review.
-
Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.Mayo Clin Proc. 2009 Sep;84(9):811-21. doi: 10.4065/84.9.811. Mayo Clin Proc. 2009. PMID: 19720779 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
